174 related articles for article (PubMed ID: 8417214)
1. Image cytometric deoxyribonucleic acid analysis of urine specimens as an adjunct to visual cytology in the detection of urothelial cell carcinoma.
Amberson JB; Laino JP
J Urol; 1993 Jan; 149(1):42-5. PubMed ID: 8417214
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder.
Giella JG; Ring K; Olsson CA; Karp FS; Benson MC
J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121
[TBL] [Abstract][Full Text] [Related]
3. Ancillary techniques in the followup of transitional cell carcinoma: a comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients.
Mora LB; Nicosia SV; Pow-Sang JM; Ku NK; Diaz JI; Lockhart J; Einstein A
J Urol; 1996 Jul; 156(1):49-54; discussion 54-5. PubMed ID: 8648836
[TBL] [Abstract][Full Text] [Related]
4. Urine: a suitable sample for deoxyribonucleic acid flow cytometry studies in patients with bladder cancer.
deVere White RW; Deitch AD; Baker WC; Strand MA
J Urol; 1988 May; 139(5):926-8. PubMed ID: 3361665
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of DNA image cytometry and urinary cytology with cells from voided urine in the detection of bladder cancer.
Planz B; Synek C; Robben J; Böcking A; Marberger M
Urology; 2000 Nov; 56(5):782-6. PubMed ID: 11068301
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
7. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder.
Slaton JW; Dinney CP; Veltri RW; Miller CM; Liebert M; O'Dowd GJ; Grossman HB
J Urol; 1997 Sep; 158(3 Pt 1):806-11. PubMed ID: 9258087
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer.
Murphy WM; Emerson LD; Chandler RW; Moinuddin SM; Soloway MS
J Urol; 1986 Oct; 136(4):815-9. PubMed ID: 3761437
[TBL] [Abstract][Full Text] [Related]
10. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of NMP22 as an adjunct to a typical urine cytology and low-grade urothelial carcinoma.
Arora VK; Sarungbam J; Bhatia A; Singh N; Agrawal V; Aggarwal S
Diagn Cytopathol; 2010 Nov; 38(11):788-90. PubMed ID: 20014314
[TBL] [Abstract][Full Text] [Related]
12. Use of mailed urine specimens in diagnosing urothelial carcinoma by cytology and DNA image analysis.
Liu J; Katz R; Shin HJ; Johnston DA; Zhang HZ; Caraway NP
Acta Cytol; 2005; 49(2):157-62. PubMed ID: 15839620
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases.
Bakhos R; Shankey TV; Flanigan RC; Fisher S; Wojcik EM
Diagn Cytopathol; 2000 Feb; 22(2):65-9. PubMed ID: 10649514
[TBL] [Abstract][Full Text] [Related]
14. Reclassification of urinary cytology regarding The Paris System for Reporting Urinary Cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma.
Anbardar MH; Monjazeb R
Diagn Cytopathol; 2020 May; 48(5):446-452. PubMed ID: 31976626
[TBL] [Abstract][Full Text] [Related]
15. Use of Lewis X antigen and deoxyribonucleic acid image cytometry to increase sensitivity of urinary cytology in transitional cell carcinoma of the bladder.
Planz B; Striepecke E; Jakse G; Böcking A
J Urol; 1998 Feb; 159(2):384-7; discussion 387-8. PubMed ID: 9649244
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of bladder cancer with urinary cytology, immunocytology and DNA-image-cytometry.
Planz B; Synek C; Deix T; Böcking A; Marberger M
Anal Cell Pathol; 2001; 22(3):103-9. PubMed ID: 11455029
[TBL] [Abstract][Full Text] [Related]
17. A clinically applicable method to preserve urine and bladder washing cells for flow cytometric monitoring of bladder cancer patients.
Deitch AD; Andreotti VA; Strand MA; Howell L; deVere White RW
J Urol; 1990 Apr; 143(4):700-5. PubMed ID: 2179581
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry based on heterogeneity index score compared with urine cytology to evaluate their diagnostic efficacy in bladder tumor.
Jitsukawa S; Tachibana M; Nakazono M; Tazaki H; Addonizio JC
Urology; 1987 Feb; 29(2):218-22. PubMed ID: 3811103
[TBL] [Abstract][Full Text] [Related]
19. DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine.
Dalquen P; Kleiber B; Grilli B; Herzog M; Bubendorf L; Oberholzer M
Cancer; 2002 Dec; 96(6):374-9. PubMed ID: 12478686
[TBL] [Abstract][Full Text] [Related]
20. Urine or bladder washings in the cytologic evaluation of transitional cell carcinoma of the urinary tract. A comparison made under routine conditions supplemented by flow cytometric DNA analysis.
Wijkström H; Lundh B; Tribukait B
Scand J Urol Nephrol; 1987; 21(2):119-23. PubMed ID: 3616503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]